Inspire Medical Systems, Inc. (FRA:2DR)
Germany · Delayed Price · Currency is EUR 106.60
-1.70 (-1.57%)
At close: Nov 28, 2025
Inspire Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 882.62 | 802.8 | 624.8 | 407.86 | 233.39 | 115.38 | Upgrade | |
Revenue Growth (YoY) | 16.81% | 28.49% | 53.19% | 74.75% | 102.28% | 40.62% | Upgrade |
Cost of Revenue | 133.14 | 122.99 | 96.58 | 66.12 | 33.28 | 17.62 | Upgrade |
Gross Profit | 749.48 | 679.82 | 528.22 | 341.74 | 200.12 | 97.76 | Upgrade |
Selling, General & Admin | 604.19 | 529.61 | 451.96 | 320.69 | 202.62 | 127.87 | Upgrade |
Research & Development | 108.56 | 114.13 | 116.54 | 68.65 | 37.35 | 26.09 | Upgrade |
Operating Expenses | 712.75 | 643.74 | 568.49 | 389.33 | 239.97 | 153.97 | Upgrade |
Operating Income | 36.73 | 36.08 | -40.27 | -47.59 | -39.85 | -56.21 | Upgrade |
Interest Expense | -0.04 | -0.02 | - | -1.68 | -2.13 | -2.12 | Upgrade |
Interest & Investment Income | 19.09 | 23.25 | 20.56 | 5.05 | 0.13 | 1.09 | Upgrade |
Currency Exchange Gain (Loss) | 0.2 | -0.9 | -0.2 | -0.1 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 0.08 | 0.05 | 0.01 | 0.05 | -0.12 | 0.15 | Upgrade |
Pretax Income | 52.01 | 58.45 | -19.91 | -44.27 | -41.97 | -57.09 | Upgrade |
Income Tax Expense | 7.46 | 4.94 | 1.25 | 0.61 | 0.07 | 0.12 | Upgrade |
Earnings From Continuing Operations | - | 53.51 | -21.15 | -44.88 | -42.04 | -57.2 | Upgrade |
Net Income | 44.56 | 53.51 | -21.15 | -44.88 | -42.04 | -57.2 | Upgrade |
Net Income to Common | 44.56 | 53.51 | -21.15 | -44.88 | -42.04 | -57.2 | Upgrade |
Shares Outstanding (Basic) | 30 | 30 | 29 | 28 | 27 | 26 | Upgrade |
Shares Outstanding (Diluted) | 30 | 31 | 29 | 28 | 27 | 26 | Upgrade |
Shares Change (YoY) | -0.77% | 4.24% | 4.38% | 2.97% | 4.56% | 9.53% | Upgrade |
EPS (Basic) | 1.51 | 1.80 | -0.72 | -1.60 | -1.54 | -2.19 | Upgrade |
EPS (Diluted) | 1.48 | 1.75 | -0.72 | -1.60 | -1.54 | -2.19 | Upgrade |
Free Cash Flow | 98.82 | 91.12 | 1.02 | 2.47 | -24.79 | -55.5 | Upgrade |
Free Cash Flow Per Share | 3.29 | 2.98 | 0.04 | 0.09 | -0.91 | -2.13 | Upgrade |
Gross Margin | 84.91% | 84.68% | 84.54% | 83.79% | 85.74% | 84.73% | Upgrade |
Operating Margin | 4.16% | 4.50% | -6.44% | -11.67% | -17.07% | -48.72% | Upgrade |
Profit Margin | 5.05% | 6.67% | -3.39% | -11.00% | -18.01% | -49.58% | Upgrade |
Free Cash Flow Margin | 11.20% | 11.35% | 0.16% | 0.61% | -10.62% | -48.10% | Upgrade |
EBITDA | 49.34 | 42.63 | -37.43 | -45.73 | -38.63 | -55.37 | Upgrade |
EBITDA Margin | 5.59% | 5.31% | -5.99% | -11.21% | -16.55% | -47.99% | Upgrade |
D&A For EBITDA | 12.61 | 6.55 | 2.85 | 1.86 | 1.22 | 0.84 | Upgrade |
EBIT | 36.73 | 36.08 | -40.27 | -47.59 | -39.85 | -56.21 | Upgrade |
EBIT Margin | 4.16% | 4.50% | -6.44% | -11.67% | -17.07% | -48.72% | Upgrade |
Effective Tax Rate | 14.34% | 8.46% | - | - | - | - | Upgrade |
Advertising Expenses | - | 94.9 | 100.3 | 74.3 | 47.8 | 26.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.